Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27451111 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL16705700 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL16705694 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL8181968 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL11175669 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL7664651 | 0.98 | TSHR (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL11177318 | 0.97 | THRB (0.61) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL14346689 | 0.95 | THRB (0.56) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL8170418 | 0.94 | TSHR (0.56) | THRBTSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL2612498 | 0.92 | THRB (0.73) | THRBTSHRALDH1A1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| CN-105051001-A | Polymerizable compound and liquid crystal composition using same | DAINIPPON INK & | 2015-11-11 | — | — | CN | disclosed |
| US-20070286968-A1 | Compound, liquid crystal composition, and their applications | FUJIFILM CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070286968-A1 | Compound, liquid crystal composition, and their applications | FUJIFILM CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1342770-B1 | Polymerizable liquid crystal compound, liquid crystal polymer and applications thereof | FUJI PHOTO FILM CO LTD (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1342770-A1 | Polymerizable liquid crystal compound, liquid crystal polymer and applications thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2003-09-10 | — | — | EP | disclosed |
| EP-0007574-B1 | LIQUID-CRYSTALLINE POLYMERIC PHASE WITH A CHOLESTERIC STRUCTURE, METHOD FOR ITS PREPARATION AND ITS USE | BASF Aktiengesellschaft (DE) | 1983-05-25 | — | — | EP | disclosed |
| US-4293435-A | ACRYLATE POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | RCC1, LPXN, SMC4 | THRB 4879/4885TSHR 4832/4885ALDH1A1 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.